Novel mutations in UL24 and gH rescue efficient infection of an HSV vector retargeted to TrkA is a research paper published in Molecular Therapy — Methods & Clinical Development (2023). On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: R01-CA222804
National Institute of Neurological Disorders and Stroke
Grant: R01-NS064988
NINDS NIH HHS
Grant: R01 NS064988
NCI NIH HHS
Grant: R01 CA222804
National Institutes of Health
Grant: 5R01CA222804-03
Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice
National Institutes of Health
Grant: 5R01NS064988-05
Glycine Receptor Expression in Sensory Afferents to Modulate Pain Signaling
National Institutes of Health
FWCI
0.85
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals